The 5th Annual Psychedelic Therapeutics and Drug Development Conference is dedicated to the research and development of psychedelics for various health conditions.
Topics
Risk Evaluation and Mitigation Strategy (REMS)
Clinical trial design
Practical use/indications/
Abuse potential
Targets for novel drug development
DEA licensure and policy considerations
Second generation psychedelic drug design
Dosage (micro/low/high)
Toxicology studies and considerations
FDA regulatory guidance
Who should Attend
Vice Presidents
Chief Executive Officers
Business Development Professionals
Chief Medical Officers
Research Scientists
Regulatory Affairs Professionals
Clinical Development Professionals
R&D Professionals
Investigators
Licensing Professionals
Chemists
Medical Chemists
Scientists
Pharmacists
Project Managers
Study Managers
Professors
Scientific Officers
Health Care Practitioners
Ph.D./Pharm.D. Students
Investors
Program Officers
Medical Directors
Analysts
Venue
DoubleTree by Hilton Hotel San Diego - Mission Valley ,
7450 Hazard Center Drive, San Diego, California, United States
The 5th Annual Psychedelic Therapeutics and Drug Development Conference - 19-20 May 2025, DoubleTree by Hilton Hotel San Diego - Mission Valley, California, United States (92194)
The 6th Annual Psychedelic Therapeutics and Drug Development Conference - May 2026, United States (94955)
Important
Please, check "The Psychedelic Therapeutics and Drug Development Conference" official website for possible changes, before making any traveling arrangements
Event Categories
Health & Medicine: Mental Health, Pharma, Psychiatry
